[Direct answer]In the Beijing area, the situation varies, and the key issue is whether the drug has defects and whether the warnings are sufficient. If the drug has defects—such as poor quality, adulteration, contamination, or deterioration, or if the instructions or labels provide insufficient warnings about adverse reactions or fail to update as required—and thereby causes personal injury, the victim may claim compensation from the producer or seller under product liability, with the option to choose either party. However, if the drug is qualified and the harm arises from an unrelated adverse reaction under normal use and dosage, it falls under the general definition of "adverse drug reactions" and does not constitute product defect liability. In this case, the victim may claim medical liability based on whether the medical institution committed medication errors (such as excessive dosage, contraindicated medication, or failure to fulfill the obligation to inform), or seek relief through the drug marketing authorization holder, relevant insurance, and assistance programs. Regardless of the approach, it is essential to first secure medical records, medication records, and the actual drug product, and consider seeking expert appraisal to clarify the causal relationship and fault.

I. Problem Background and Typical Scenarios

After taking medication, experiencing serious adverse reactions is a distressing experience for patients and their families. A typical scenario is: after taking a certain medication according to the doctor's instructions, the patient experiences severe allergies, liver and kidney damage, etc. The family believes that the drug is defective and demands compensation from the manufacturer; the manufacturer, however, defends itself by saying "the drug is qualified and the reaction is a known adverse reaction". The disputes focus on whether the drug is defective, the causality of the damage, and the attribution of responsibility.

II. Key points of contention

First, the distinction between drug defects and "adverse reactions"; second, the review of quality standards and warnings in product manuals; third, the division of responsibilities among producers, sellers, and medical institutions; fourth, the identification of causal relationships; and fifth, the selection of remedial pathways. In practice, the identification of defects and the determination of causal relationships are the core issues.

III. Professional analysis by Henglue Lawyers

The first layer: The premise of product liability is defects. If a drug poses an unreasonable risk to personal safety when it is put into circulation, or if it fails to meet national drug standards, it constitutes a defect, and product liability can be claimed based on this; the drug marketing authorization holder, producers, and sellers shall be held liable according to law. The second layer: The obligation to provide warnings in product instructions. Even if the drug is qualified, if its product instructions or labels fail to adequately warn of known serious adverse reactions, or if they are not revised in a timely manner in accordance with regulatory requirements, resulting in users being unable to take precautions, they may also bear liability due to a lack of warnings. The third layer: The distinction from "adverse drug reactions". Harmful reactions to a drug that occur under normal use and dosage but are unrelated to the intended purpose of the drug are considered adverse reactions and generally do not constitute product defects; these are inherent risks of the drug, and liability determination should focus on whether there are defects, a lack of warnings, or medication errors. The fourth layer: Medical institution medication errors. If the harm stems from excessive dosage, violation of contraindications, improper compatibility, or failure to fulfill the obligation to provide information, patients can claim medical liability against the medical institution; this path focuses on the causality and fault of the medical treatment. The fifth layer: Evidence collection and appraisal. Patients should preserve medical records, prescriptions, drug samples and packaging, and purchase receipts, and apply for causality and fault appraisals; if serious health damage is caused by drug defects, they can also claim punitive damages in accordance with regulations. Henglue Lawyers' Tip: Such cases are highly specialized, and it is important to fix evidence and entrust professional institutions for appraisal as soon as possible to avoid missing critical deadlines.

IV. Practical suggestions and legal basis

The first step is to preserve the medical records, prescriptions, medication records, and the actual drugs, packaging, and purchase receipts; the second step is to determine whether the drugs have quality or warning defects, or whether they are adverse reactions to qualified drugs; the third step is to claim medical liability from the medical institution if there is a medication error; the fourth step is to claim product liability from the manufacturer or seller if there are drug defects; the fifth step is to apply for causality and fault appraisal when necessary, and seek remedies through complaints, litigation, or assistance channels. The main legal basis: Articles 1202, 1203, and 1221 of the Civil Code of the People's Republic of China; relevant provisions of the Drug Administration Law of the People's Republic of China. The specific application shall be subject to the currently effective regulations.

5. Henglu Law Firm's Reminder

Three sentences on adverse drug reactions: If it's a defect, the manufacturer or seller should be held liable for compensation; if it's a normal reaction to a qualified drug, it's generally not considered product liability. If the product instructions lack sufficient warnings or the doctor administered the drug improperly, other legal remedies may be pursued. It's essential to keep all relevant records, including medical records, prescriptions, drugs, and receipts, and to conduct an appraisal as soon as possible. For cases involving personal injury and medical disputes, legal action may be taken through appropriate channels.Personal injury and medical disputesThe service obtains an overall solution, which involves the integration of product contracts and claimsBusiness and contract disputes in enterprisesFor reference, please refer to the section on corporate drug and product complianceIntellectual property protection and corporate lawFor those who need advice on difficult medical malpractice cases, they can consult the columnSpecial servicesTeam.

VI. Frequently Asked Questions

Q1: If I experience adverse reactions after taking the medication, can I report them to the manufacturer?

It depends on the specific circumstances. If the drug has quality defects or insufficient warnings in the instructions, you can claim compensation from the producer or seller based on product liability; if the drug is qualified and the adverse reaction occurs under normal usage and dosage, you generally cannot claim compensation based on product liability, but you can review whether the medical institution has made medication errors and seek remedies through other channels such as medical damage. It is recommended to first secure evidence and conduct an appraisal.

Q2: What constitutes a drug defect?

It generally refers to the situation where drugs do not meet national drug standards, or there are unreasonable dangers that endanger personal safety, as well as insufficient warnings in the instructions and labels. The inherent adverse reactions of qualified drugs under normal usage and dosage are generally not considered defects. Whether it constitutes a defect can be determined by referring to quality standards, inspection conclusions, and the review of the instructions, and if necessary, an appraisal can be applied for.

Q3: Can a doctor be sued individually for medical malpractice?

Yes. If the damage stems from medical malpractice such as overdosing, violating contraindications, improper compatibility, or failing to fulfill the obligation to inform, patients can claim medical damage liability from medical institutions. This path focuses on the relationship between fault and causality, and typically requires a medical damage appraisal to determine the proportion of liability. It can be evaluated in parallel with the product liability path, and the claimant can choose the most advantageous path to pursue their rights.

Q4: What appraisals are required to be conducted?

Common examples include drug quality inspections, causality assessments, and medical damage assessments in cases involving diagnostic or treatment errors. These assessments can clarify whether the damage was caused by the drug or the diagnostic or treatment procedures, as well as the degree of responsibility and the level of involvement. It is recommended to determine the assessment items, timing, and institutions under the guidance of professional lawyers to avoid improper assessments affecting the determination of liability.

Q5: If the claim is unsuccessful, are there any other remedies available?

Multiple paths can be pursued in parallel. In addition to claiming compensation from producers, sellers, or medical institutions, one can also file complaints and reports with drug regulatory authorities to report issues related to drug quality and adverse reactions. If necessary, seek assistance through relevant insurance and relief mechanisms. It is recommended to consult a professional lawyer as soon as possible to comprehensively evaluate the difficulty of providing evidence and feasible solutions for each path.

The above Q&A is mainly based on the judicial practice in the Beijing area. There may be differences in the adjudication opinions in different regions. It is recommended to consult a professional lawyer based on the specific circumstances of the case.

If you are facing similar problems, it is recommended that you consult a professional lawyer as soon as possible with the evidence materials, so as to avoid missing the statutory time limit. →Personal injury legal services·Beijing Henglu Law Firm

Disclaimer: This article is compiled based on the current effective laws and regulations and public adjudication rules, and is for general reference only. It does not constitute a formal legal opinion on specific cases. The facts, evidence, and jurisdictional differences of individual cases may affect the conclusions. If you encounter disputes, please consult a practicing lawyer in time.